Terapia con células madre para el daño renal crónico inducido por sustancias tóxicas
Enfermedad renal crónica (ERC) is a global health concern with limited therapeutic options. Toxic insults, such as exposure to heavy metals, drogas, y contaminantes ambientales, can induce CKD, leading to irreversible loss of renal function. Stem cell therapy has emerged as a promising approach to regenerate damaged renal tissue and restore kidney function. This article reviews the pathogenesis of toxic-induced CKD, El potencial terapéutico de las células madre., and the current status of preclinical and clinical research in stem cell therapy for kidney damage.
Pathogenesis of Toxic-Induced Chronic Kidney Disease
Toxic substances can damage renal cells through various mechanisms, incluido el estrés oxidativo, inflamación, y apoptosis. Heavy metals, such as lead and cadmium, accumulate in the kidney and induce oxidative damage, leading to tubular necrosis and interstitial fibrosis. Drugs, como medicamentos antiinflamatorios no esteroides (AINE) and antibiotics, can cause direct toxicity to renal cells, resulting in tubular injury and inflammation. Environmental pollutants, such as polychlorinated biphenyls (PCBs) and dioxins, can also induce kidney damage through oxidative stress and immune-mediated mechanisms.
Renal Stem Cells and Their Therapeutic Potential
The kidney contains several types of stem cells, including resident renal stem cells and circulating stem cells. Resident renal stem cells are located in the Bowman’s capsule, proximal tubules, and collecting ducts. These stem cells have the potential to self-renew and differentiate into various renal cell types, incluyendo podocitos, células epiteliales tubulares, y células mesangiales. Circulating stem cells, como las células madre mesenquimales (MSC) y células madre hematopoyéticas (HSC), can also contribute to kidney regeneration after injury.
Mesenchymal Stem Cells in Kidney Regeneration
MSCs are multipotent stromal cells that can differentiate into a variety of cell types, incluyendo osteoblastos, condrocitos, y adipocitos. MSCs have been shown to have therapeutic effects in preclinical models of kidney damage. They can migrate to the injured kidney, differentiate into renal cells, y promover la reparación de tejidos. MSCs also secrete paracrine factors that have anti-inflammatory, antiapoptótico, and pro-angiogenic effects, contributing to the regeneration of damaged renal tissue.
Hematopoietic Stem Cells and Renal Repair
HSCs are pluripotent stem cells that can give rise to all blood cell lineages. HSCs have been shown to have renoprotective effects in preclinical models of kidney damage. Pueden diferenciarse en células renales., including tubular epithelial cells and endothelial cells, and contribute to the repair of damaged tissue. HSCs also secrete paracrine factors that promote cell survival, proliferación, y diferenciación, contributing to the regeneration of the injured kidney.
La información contenida en esta página está destinada a fines científicos., educativo, y fines informativos generales.. Enfoques clínicos, disponibilidad, y el estado regulatorio puede variar según el país, institución, e indicación médica. Para decisiones médicas individuales, Los lectores deben consultar a profesionales sanitarios cualificados y centros médicos acreditados..
Este artículo ha sido elaborado por el equipo editorial de NBScience en el ámbito de la investigación clínica., biotecnología, e información médica internacional.
